PF-00299804

A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called protein tyrosine kinase inhibitors.

Sustancia en estudio para el tratamiento del cáncer. Pertenece al tipo de medicamentos llamados inhibidores de la tirosina cinasa.